Oncotype DX? Breast Cancer Test Predicts Late Recurrence Five to 15 Years Out
There are 1 comment on the Applied Clinical Trials story from May 29, 2014, titled Oncotype DX? Breast Cancer Test Predicts Late Recurrence Five to 15 Years Out. In it, Applied Clinical Trials reports that:
New Data Presented at ASCO Annual Meeting Suggest that Genomic Health's Oncotype DX Test May Help Identify Patients That Have the Greatest Opportunity to Benefit from Extended Hormonal Therapy New Data Presented at ASCO Annual Meeting Suggest that Genomic Health's Oncotype DX Test May Help Identify Patients That Have the Greatest Opportunity to ... (more)
Join the discussion below, or Read more at Applied Clinical Trials.
#1 May 29, 2014
Why waste peoples time with a test that predicts a RECURRENCE? Solve the damn puzzle and find the cure you idiots. Your record thus far sucks. You've been at it for 80 years and still women are dying while you spend billions on RESEARCH.
Add your comments below
|Racially biased cancer doctors spend less time ...||Jun 25||Summer Friend||6|
|Please help our daughter||Jun 4||smiley||3|
|'Mammograms hurt' column draws ire -- OrlandoSe... (Aug '07)||May '16||debbie 1889||198|
|ESCOZUL is healing cancer patients (Mar '07)||May '16||spiroshouse||161|
|CANCER REDACTING langham cancer research der... (Dec '15)||May '16||andrew john langham||5|
|Essiac tea-not working, Anyone found a stronger... (Jun '11)||May '16||Hamandegger||13|
|Lower odds of lung cancer surgery for blacks in...||May '16||White and Right||1|
Find what you want!
Search Cancer Forum Now
Copyright © 2016 Topix LLC